NCT02831634View on ClinicalTrials.gov

A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope)

NACompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

June 9, 2016

Primary Completion Date

March 1, 2018

Study Completion Date

March 1, 2018

Conditions

Breast CancerCutaneous Melanoma

Interventions

PROCEDURE

Blood sampling

After inclusion in the protocol, a blood sample (50 mL in EDTA tubes) will be withdrawn during pre-operative consultation.

Trial Locations (1)

75005

Institut Curie, Paris

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Institut Curie

OTHER